HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist.

Abstract
Antagonists for the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor may have therapeutic potential as neuroprotectant agents in conditions of neuronal degeneration that include brain ischemia, Huntington's chorea, and Alzheimer's disease. Here we have investigated the pharmacological actions of LY274614, a structurally novel competitive NMDA receptor antagonist, for pharmacological selectivity and neuroprotectant effects following systemic administration. LY274614 potently displaced NMDA receptor ([3H]CGS19755) binding (IC50 = 58.8 +/- 10.3 nM), but had no appreciable affinity at [3H]AMPA or [3H]kainate receptor sites at up to 10,000 nM. NMDA-induced convulsions in neonatal rats or NMDA-induced lethality in mice are potently and selectively antagonized by i.p. or p.o. LY274614. Oral doses showed a delayed but prolonged duration of effect. In adult rats, the neurodegenerative effects (loss of choline acetyltransferase activity) following the intrastriatal infusions of NMDA or quinolinate, but not kainate, were prevented by LY274614 (2.5 to 20 mg/kg i.p.). LY274614 is an effective neuroprotectant agent against NMDA receptor-induced toxicity when administered systemically and is a promising therapeutic agent for conditions where glutamate plays a role in the pathology of neuronal degeneration.
AuthorsD D Schoepp, P L Ornstein, C R Salhoff, J D Leander
JournalJournal of neural transmission. General section (J Neural Transm Gen Sect) Vol. 85 Issue 2 Pg. 131-43 ( 1991) Austria
PMID1834088 (Publication Type: Journal Article)
Chemical References
  • Anticonvulsants
  • Isoquinolines
  • Receptors, N-Methyl-D-Aspartate
  • LY 274614
  • Ibotenic Acid
  • N-Methylaspartate
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
  • Quisqualic Acid
  • Kainic Acid
Topics
  • Animals
  • Anticonvulsants
  • Binding, Competitive
  • Brain (physiology)
  • Dose-Response Relationship, Drug
  • Female
  • Ibotenic Acid (analogs & derivatives, metabolism)
  • Isoquinolines
  • Kainic Acid (metabolism)
  • Male
  • N-Methylaspartate (antagonists & inhibitors, metabolism)
  • Nerve Degeneration (drug effects)
  • Quisqualic Acid (metabolism)
  • Radioligand Assay
  • Rats
  • Rats, Inbred Strains
  • Receptors, N-Methyl-D-Aspartate (antagonists & inhibitors)
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: